Stan Ra, CIO of Seattle Children’s, has been the driving force behind the hospital’s investment strategy since 2016. As the organization’s first dedicated chief investment officer, Ra built ...

Things have been unexpectedly gloomy for private equity exits this year, despite earlier hopes for a resurgence in the first ...

Institutional Investor was proud to recognize leaders within the allocator community for their outstanding contributions to ...

Kasia Karapuda, CFA, is a recipient of the Women in Investment Management Recognition. Before she assumed her current role of ...

Institutional Investor was proud to recognize leaders within the allocator community for their outstanding contributions to ...

This year, Institutional Investor is honoring 10 Rising Stars in the hedge fund industry. The talented professionals in this elite group are recognized for their outstanding contributions and ...

55+ Years of Analysis & Insight . For more than 55 years, Institutional Investor has delivered the news and analysis that investment professionals need to succeed and stay relevant.

Sylebra Capital surged on a few contrarian bets, though it remains slightly down for the year. Lone Pine, D1, and Maverick all extended their strong 2025 runs, while others like Tiger Global and ...

Most biopharma and life sciences hedge funds continued to struggle in May in what is shaping up to be one of the worst years in recent memory for the strategy. Many funds are down by double-digit ...

Each of these indicators mentioned bear watching, however. If higher-than-average market volatility and more consumer stress were to continue, history suggests they could exacerbate stressed debt ...

Almost half of institutional investors in North America expect volatility to be greater in the next 12 months than it was during the global financial crisis. That stunning statistic was part of ...